Binomial Probability Distribution
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Bias
Strategies for Assessing and Addressing Confounding
Testing a Claim about Population Proportion
Assumptions of Survival Analysis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 20, 2025

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
1Division of Biometrics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
Estimating secondary attack risk (SAR) using simple binomial models is flawed. These models overestimate infection risk and provide inaccurate confidence intervals, even for small probabilities, failing to account for multiple transmission generations.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: